Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medibank Private ( (AU:MPL) ) just unveiled an update.
Medibank Private’s 2025 full-year results highlight its strong growth and customer focus, with record customer numbers and a significant increase in net policyholder growth. The company has maintained a high customer retention rate and continued to expand its offerings, including the Live Better rewards program and no gap networks. Medibank’s financial performance was robust, with an 8.5% increase in underlying net profit after tax and a fully franked final ordinary dividend of 10.2 cents per share. The company is investing heavily in mental health and prevention, positioning itself for future growth and contributing significantly to the health insurance industry’s total spend on prevention.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.10 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private is a prominent player in the health insurance industry, offering a range of health and wellbeing services. The company focuses on providing value to its customers amidst cost-of-living pressures and aims to support the health system’s future. Medibank is noted for its strong capital position, low management expenses, and significant investment in health prevention and mental health initiatives.
Average Trading Volume: 5,581,142
Technical Sentiment Signal: Buy
Current Market Cap: A$14.05B
Learn more about MPL stock on TipRanks’ Stock Analysis page.